SCHEMBL5360487

SCHEMBL5360487

ON=Cc1csc2ccccc12

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2A6 P11509 3/20 0.60
CA12 O43570 1/20 0.49
CA1 P00915 1/20 0.49
CA2 P00918 1/20 0.49
CA9 Q16790 1/20 0.49
PTGS1 P23219 1/20 0.47
PTGS2 P35354 1/20 0.47
MAPT P10636 3/20 0.46
ALDH1A1 P00352 3/20 0.46
TDP1 Q9NUW8 2/20 0.46
MEN1 O00255 2/20 0.46
KMT2A Q03164 2/20 0.46
PKM P14618 2/20 0.46
KDM4E B2RXH2 1/20 0.46
KDM4C Q9H3R0 1/20 0.46
HPGD P15428 1/20 0.46
HTT P42858 1/20 0.46
MAOB P27338 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
TUBB4A P04350 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16693129 1.00 CYP2A6 (0.60) CYP2A6CA12CA1CA2CA9
SCHEMBL15930269 0.83 CYP2A6 (0.64) CYP2A6CA12CA1CA2CA9
SCHEMBL14370918 0.80 CYP2A6 (0.60) CYP2A6CA12CA1CA2CA9
SCHEMBL6811378 0.77 CYP2A6 (0.50) CYP2A6CA12CA1CA2CA9
SCHEMBL6811377 0.77 CYP2A6 (0.50) CYP2A6CA12CA1CA2CA9
SCHEMBL12757025 0.76 CYP2A6 (0.55) CYP2A6CA12CA1CA2CA9
SCHEMBL8996553 0.75 CYP2A6 (0.64) CYP2A6CA12CA1CA2CA9
SCHEMBL30076672 0.75 CYP2A6 (1.00) CYP2A6CA12CA1CA2CA9
SCHEMBL40953 0.75 CYP2A6 (1.00) CYP2A6CA12CA1CA2CA9
SCHEMBL11708827 0.75 CYP2A6 (0.64) CYP2A6CA12CA1CA2CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7276518-B2 Substituted cyclohexane-1,4-diamine compounds GRUENENTHAL GMBH (DE) 2007-10-02 US disclosed
US-20040229872-A1 Substituted cyclohexane-1,4-diamine compounds with anti-diarrhea and peripheral analgesic activity GRUENENTHAL GMBH (DE) 2004-11-18 US disclosed
US-20040162287-A1 Substituted cyclohexane-1,4-diamine compounds GRUENENTHAL GMBH (DE) 2004-08-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040162287-A1 Substituted cyclohexane-1,4-diamine compounds DPYD, DDC, QDPR CYP2A6 94/4885CA12 1212/4885CA1 1122/4885
US-20040229872-A1 Substituted cyclohexane-1,4-diamine compounds with anti-diarrhea and peripheral analgesic activity ARG1, CD2, PDCD1 CYP2A6 616/4885CA12 3160/4885CA1 1637/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.